The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Life Science Market Reports

SynopsisGenetic toxicology is a branch of toxicology that focuses on the study of the genetic damage or mutations caused by various physical, chemical, and biological agents. These agents, often referred to as genotoxic agents, have the potential to alter the genetic .....

No Of Pages : 94
Publication Date: Mar, 2025
Single User Price : US$ 2,900.00

SynopsisThe global Levofloxacin market was valued at US$ 1900 million in 2023 and is anticipated to reach US$ 2620.1 million by 2030, witnessing a CAGR of 4.7% during the forecast period 2024-2030. North American market for Levofloxacin is estimated to increase .....

No Of Pages : 96
Publication Date: Mar, 2025
Single User Price : US$ 2,900.00

SynopsisRivastigmine (sold under the trade name Exelon among others) is a cholinesterase inhibitor used for the treatment of mild to moderate Alzheimer's disease. The drug can be administered orally or via a transdermal patch; the latter form reduces the prevalence of.....

No Of Pages : 80
Publication Date: Mar, 2025
Single User Price : US$ 2,900.00

SynopsisConjunctivitis, or pink eye, is inflammation of the outermost layer of the white part of the eye and the inner surface of the eyelid due to numerous causes the most common being bacterial infection. The condition is self-limiting, but in some cases results in.....

No Of Pages : 79
Publication Date: Mar, 2025
Single User Price : US$ 2,900.00

SynopsisMalar implant is a facial implant designed to enhance the appearance of the cheekbones for aesthetic purposes. The global Malar Implant market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % durin.....

No Of Pages : 89
Publication Date: Mar, 2025
Single User Price : US$ 2,900.00

SynopsisAntihemorrhagic Agent is a substance that promotes hemostasis (stops bleeding). The global Antihemorrhagic Agent market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significan.....

No Of Pages : 108
Publication Date: Mar, 2025
Single User Price : US$ 3,350.00

SynopsisPegvisomant(trade name Somavert) is a growth hormone receptor antagonist used in the treatment of acromegaly. The global Pegvisomant market size is expected to reach US$ 331.5 million by 2029, growing at a CAGR of 3.1% from 2023 to 2029. The market is ma.....

No Of Pages : 75
Publication Date: Mar, 2025
Single User Price : US$ 3,350.00